BlossomHill Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
BlossomHill Therapeutics, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include BLOSSOMHILL THERAPEUTICS. The owner is based in San Diego, CA.
3525 John Hopkins Court, Suite 100
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
BlossomHill Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BlossomHill Therapeutics, Inc. have?
BlossomHill Therapeutics, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does BlossomHill Therapeutics, Inc. file in?
BlossomHill Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BlossomHill Therapeutics, Inc.'s most well-known trademarks?
BlossomHill Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as BLOSSOMHILL THERAPEUTICS. These are among 2 currently registered trademarks in the portfolio.
What is BlossomHill Therapeutics, Inc.'s trademark registration success rate?
BlossomHill Therapeutics, Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.